Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status

about

Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status

Item

http://www.wikidata.org/entity/Q57176137

description

scientific article published on 13 July 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Combined ATR and DNA-PK Inhibi ...... ependently of Their p53 Status

@en

Combined ATR and DNA-PK Inhibi ...... ependently of Their p53 Status

@nl

type

Item

label

Combined ATR and DNA-PK Inhibi ...... ependently of Their p53 Status

@en

Combined ATR and DNA-PK Inhibi ...... ependently of Their p53 Status

@nl

prefLabel

Combined ATR and DNA-PK Inhibi ...... ependently of Their p53 Status

@en

Combined ATR and DNA-PK Inhibi ...... ependently of Their p53 Status

@nl

P1476

Combined ATR and DNA-PK Inhibi ...... ependently of Their p53 Status

@en

P2093

Hind Hafsi

http://www.w3.org/2001/XMLSchema#string

Holly E Barker

http://www.w3.org/2001/XMLSchema#string

James T Paget

http://www.w3.org/2001/XMLSchema#string

Joan N Kyula

http://www.w3.org/2001/XMLSchema#string

Kevin J Harrington

http://www.w3.org/2001/XMLSchema#string

Malin Pedersen

http://www.w3.org/2001/XMLSchema#string

Ulrike Schick

http://www.w3.org/2001/XMLSchema#string

P2860

Beyond DNA repair: DNA-PK function in cancer

Chromothripsis from DNA damage in micronuclei.

The DNA Damage Response: Making It Safe to Play with Knives

Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma

Cell cycle regulation of human DNA repair and chromatin remodeling genes

DNA-PKcs expression predicts response to radiotherapy in prostate cancer

The HSP90 inhibitor NVP-AUY922 radiosensitizes by abrogation of homologous recombination resulting in mitotic entry with unresolved DNA damage

DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression.

Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

P304

245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2018.00245

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Magnus T Dillon

Henry G Smith

Martin McLaughlin

P577

2018-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30057890

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6053502

http://www.w3.org/2001/XMLSchema#string